CAR T cell receptor immunotherapy targeting VEGFR2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CAR T cell receptor immunotherapy targeting VEGFR2, covering 2016-07-22 to 2016-07-22. Get the full timeline:
Most recent: Clinical Trial Update: CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer [Phase 1, Phase 2]